# Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model

> **NCT07104253** · NA · NOT_YET_RECRUITING · sponsor: **Endocision Technologies Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DEVICE:** Ex vivo cryo-ablation

## Key facts

- **NCT ID:** NCT07104253
- **Lead sponsor:** Endocision Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07104253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07104253, "Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07104253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*